Author Correction: Tau-targeting antisense oligonucleotide MAPTRxin mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
- Resource Type
- Article
- Authors
- Mummery, Catherine J.; Börjesson-Hanson, Anne; Blackburn, Daniel J.; Vijverberg, Everard G. B.; De Deyn, Peter Paul; Ducharme, Simon; Jonsson, Michael; Schneider, Anja; Rinne, Juha O.; Ludolph, Albert C.; Bodenschatz, Ralf; Kordasiewicz, Holly; Swayze, Eric E.; Fitzsimmons, Bethany; Mignon, Laurence; Moore, Katrina M.; Yun, Chris; Baumann, Tiffany; Li, Dan; Norris, Daniel A.; Crean, Rebecca; Graham, Danielle L.; Huang, Ellen; Ratti, Elena; Bennett, C. Frank; Junge, Candice; Lane, Roger M.
- Source
- Nature Medicine; January 2024, Vol. 30 Issue: 1 p304-304, 1p
- Subject
- Language
- ISSN
- 10788956; 1546170X